港股生物技术板块持续走低

Core Viewpoint - The biotechnology sector in Hong Kong is experiencing a significant decline, with several companies facing substantial stock price drops [1] Group 1: Company Performance - Gilead Sciences (歌礼制药, 01672.HK) has seen its stock price drop by over 8% [1] - Sanofi (圣诺医药, 02257.HK) has experienced a decline of more than 6% [1] - Other companies such as BeiGene (百济神州, 06160.HK) and Innovent Biologics (复宏汉霖, 02696.HK) are also following the downward trend [1]